Recent trials have produced conflicting results on the benefit of epinephrine in patients with OHCA. PARAMEDIC2 was just published and is the largest randomized double-blind, placebo-controlled trial to evaluate the use of epinephrine in OHCA. Dr. Rory Spiegel joins…
![](https://i0.wp.com/ccpem.blog/wp-content/uploads/2019/02/891166_85bd27f3b65d42efac2d4478ccf09220_mv2.jpg?fit=1000%2C662&ssl=1)